Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Carlsson SV"'
Publikováno v:
Advances in experimental medicine and biology, 867, 93-114. Springer New York
In this chapter the use of prostate specific antigen (PSA) as a tumor marker for prostate cancer is discussed. The chapter provides an overview of biological and clinical aspects of PSA. The main drawback of total PSA (tPSA) is its lack of specificit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::e729de3042409bdce9e06a3249dab541
https://pure.eur.nl/en/publications/60369783-f097-49ee-a4a6-dee97d48c2c1
https://pure.eur.nl/en/publications/60369783-f097-49ee-a4a6-dee97d48c2c1
Autor:
Carlsson, SV, Peltola, MT, Sjoberg, D, Schröder, Fritz, Hugosson, J, Pettersson, K, Scardino, PT, Vickers, AJ, Lilja, H, Roobol - Bouts, Monique
Publikováno v:
BJU International, 112(5), 602-609. Wiley-Blackwell Publishing Ltd
Objective To explore whether a panel of kallikrein markers in blood: total, free and intact prostate-specific antigen (PSA) and kallikrein-related peptidase 2, could be used as a non-invasive alternative for predicting prostate cancer on biopsy in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::03804384cacf83222de6de899843bf1a
https://europepmc.org/articles/PMC3675187/
https://europepmc.org/articles/PMC3675187/
Autor:
Roobol - Bouts, Monique, Carlsson, SV
Publikováno v:
Nature Reviews Urology, 10(5), 248-248. Nature Publishing Group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::d07fa808cdcf2f2d4f843ce0c7185a06
https://pure.eur.nl/en/publications/739588d8-bc93-4066-8f9f-76ef0dddd690
https://pure.eur.nl/en/publications/739588d8-bc93-4066-8f9f-76ef0dddd690
Autor:
Carlsson, SV, Holmberg, E, Moss, SM, Roobol - Bouts, Monique, Schröder, Fritz, Tammela, TLJ, Aus, G, Auvinen, AP, Hugosson, J
Publikováno v:
BJU International, 107(12), 1912-1917. Wiley-Blackwell Publishing Ltd
Level of Evidence 1b What's known on the subject? and What does the study add? Prostate biopsy can potentially have fatal outcome. This is, however, rare. In the literature a few fatal cases of septicaemia have been reported as well as life-threateni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::d45be6022fdbc79f9d7c530018e08eed
https://pure.eur.nl/en/publications/afc213de-d43f-486d-a9d2-abf13156c7f2
https://pure.eur.nl/en/publications/afc213de-d43f-486d-a9d2-abf13156c7f2
Autor:
Ganjaei KG; Pulmonary Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Wong KA; Pulmonary Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Strauss SM; NYU Rory Meyers College of Nursing, New York, New York, USA.; Department of Nursing Research, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Carlsson SV; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Barton-Burke M; Department of Nursing Research, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Tan M; Pulmonary Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Division of Sleep Medicine, Department of Psychiatry, Stanford University School of Medicine, Palo Alto, California, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2024 Nov; Vol. 13 (21), pp. e7198.
Autor:
Carlsson SV; Department of Surgery (Urology Service) and Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.; Department of Translational Medicine, Division of Urological Cancers, Medical Faculty, Lund University, Lund, Sweden., Oh WK; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
Publikováno v:
JAMA oncology [JAMA Oncol] 2024 Nov 01; Vol. 10 (11), pp. 1497-1498.
Autor:
Oh WK; Division of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: william.oh@mssm.edu., Agarwal N; Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. Electronic address: neeraj.agarwal@hci.utah.edu., Bryce A; Department of Medical Oncology and Therapeutics Research, City of Hope Phoenix, Phoenix, AZ, USA., Barata P; University Hospitals Seidman Cancer Center, Cleveland, OH, USA., Bugler C; Zero Prostate Cancer, Washington, DC, USA., Carlsson SV; Departments of Surgery (Urology Service) and Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Urology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden; Department of Translational Medicine, Division of Urological Cancers, Lund University, Lund, Sweden., Cornell B; Patient advocate., Dahut W; American Cancer Society, Atlanta, GA, USA., George D; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., Loeb S; Department of Urology and Population Health, New York University Langone Health and Manhattan Veterans Affairs, New York, NY, USA., Montgomery B; Division of Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA; Fred Hutchinson Cancer Center, Seattle, WA, USA., Morris D; Urology Associates PC, Nashville, TN, USA., Mucci LA; American Cancer Society, Atlanta, GA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Omlin A; Onkozentrum Zürich und Uroonkologisches Zentrum, Hirslanden Zürich, Zurich, Switzerland., Palapattu G; Department of Urology, University of Michigan, Ann Arbor, MI, USA., Riaz IB; Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA., Ryan C; Zero Prostate Cancer, Washington, DC, USA / University of Minnesota, Minneapolis, MN, USA., Schoen MW; Department of Internal Medicine, St. Louis University School of Medicine, St. Louis, MO, USA., Washington SL 3rd; Department of Urology, University of California-San Francisco, San Francisco, CA, USA., Gillessen S; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.
Publikováno v:
European urology [Eur Urol] 2024 Oct 28. Date of Electronic Publication: 2024 Oct 28.
Autor:
Carlsson SV; Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden; Department of Translational Medicine, Division of Urological Cancers, Lund University, Lund, Sweden., Lilja H; Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Vickers AJ; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bjartell AS; Department of Translational Medicine, Division of Urological Cancers, Lund University, Lund, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden. Electronic address: anders.bjartell@med.lu.se.
Publikováno v:
European urology [Eur Urol] 2024 Sep 25. Date of Electronic Publication: 2024 Sep 25.
Autor:
Bjerner J; Department of Clinical Chemistry, Fürst Laboratories, Oslo, Norway., Bratt O; Department of Urology, Institute of Clinical Sciences, Gothenburg University, Gothenburg, Sweden; Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden., Aas K; Department of Urology, Oslo University Hospital, Oslo, Norway., Albertsen PC; Division of Urology, Department of Surgery, University of Connecticut Health Center, Farmington, CT, USA., Carlsson SV; Department of Urology, Institute of Clinical Sciences, Gothenburg University, Gothenburg, Sweden; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Oldenburg J; Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Oncology, Akershus University Hospital, Lørenskog, Norway. Electronic address: jan.oldenburg@medisin.uio.no.
Publikováno v:
European urology [Eur Urol] 2024 Sep 17. Date of Electronic Publication: 2024 Sep 17.
Autor:
Carlsson SV; Departments of Surgery (Urology Service) and Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sweden.; Division of Urological Cancers, Department of Translational Medicine, Medical Faculty, Lund University, Lund, Sweden., Carroll PR; Department of Urology, USCF - Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco., Hamdy FC; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
Publikováno v:
The Journal of urology [J Urol] 2024 Sep 17, pp. 101097JU0000000000004253. Date of Electronic Publication: 2024 Sep 17.